Biden Considering Robert Califf, a Former F.D.A. Commissioner, to Direct Company Once more
WASHINGTON — The White Property is thinking about nominating Dr. Robert M. Califf, a previous Food stuff and Drug Administration commissioner, to at the time once again lead the agency, according to 5 people today acquainted with the lookup for a prospect.
The F.D.A. has been devoid of a long lasting chief considering that President Biden took workplace, primary to regular criticism from general public wellbeing professionals who have stated the company has lacked apparent way all through an rigorous period of the pandemic, even though it has faced a crush of opinions of coronavirus vaccines, checks and therapies.
The persons familiar with the research system explained that no ultimate determination had been made. The acting F.D.A. commissioner, Dr. Janet Woodcock, a longtime drug regulator, is nearing the stop of the expression that acting officers are authorized to provide.
Dr. Califf declined to remark. News of his probable nomination was initially claimed by The Washington Post.
Dr. Califf, a cardiologist who teaches at the Duke College Faculty of Drugs, served only briefly as F.D.A. commissioner, at the end of President Barack Obama’s next expression. He was the agency’s deputy commissioner for health-related solutions and tobacco before main it from February 2016 to January 2017.
He was verified by the Senate as commissioner in February 2016 in a vote of 89 to 4, just after some lawmakers opposed his nomination over what they reported was the agency’s poor file on prescription painkillers. His nomination faced its fiercest pushback from Democrats.
Katie Rogers, Sharon LaFraniere and Katie Thomas contributed reporting.
WASHINGTON — The White Property is thinking about nominating Dr. Robert M. Califf, a previous Food stuff and Drug Administration commissioner, to at the time once again lead the agency, according to 5 people today acquainted with the lookup for a prospect.
The F.D.A. has been devoid of a long lasting chief considering that President Biden took workplace, primary to regular criticism from general public wellbeing professionals who have stated the company has lacked apparent way all through an rigorous period of the pandemic, even though it has faced a crush of opinions of coronavirus vaccines, checks and therapies.
The persons familiar with the research system explained that no ultimate determination had been made. The acting F.D.A. commissioner, Dr. Janet Woodcock, a longtime drug regulator, is nearing the stop of the expression that acting officers are authorized to provide.
Dr. Califf declined to remark. News of his probable nomination was initially claimed by The Washington Post.
Dr. Califf, a cardiologist who teaches at the Duke College Faculty of Drugs, served only briefly as F.D.A. commissioner, at the end of President Barack Obama’s next expression. He was the agency’s deputy commissioner for health-related solutions and tobacco before main it from February 2016 to January 2017.
He was verified by the Senate as commissioner in February 2016 in a vote of 89 to 4, just after some lawmakers opposed his nomination over what they reported was the agency’s poor file on prescription painkillers. His nomination faced its fiercest pushback from Democrats.
Katie Rogers, Sharon LaFraniere and Katie Thomas contributed reporting.